In January 2020, we raised $74,191 in new donations and pledges from 845 supporters. Of that amount, $72,227 was for general support, $921 for Phase 3, $753 for Harm Reduction, and $250 for Ibogaine Research. Additional funds were raised for fiscal sponsorships ($8,416).
We launched our year-end fundraising campaign, Expanding Psychedelic Medicine, on November 19, 2019. Over 1,450 donors from 36 different countries helped us exceed our initial fundraising goal, raising a total of $908,943 for psychedelic research and education! We are particularly grateful to our supporters who offered matching grants including John A. Griffin ($100,000), Frank Kavanaugh ($25,000), Matt Khoury ($15,000) and the TinMan Fund ($10,000).
We extend a special thanks to those who so generously supported MAPS last month:
- Chris Ergen via The Telluray Fund – $20,000
- Maeve Rockefeller – $10,000
- Colin Wilson – $3,000
- Anonymous – $2,000
- Jody Uttal and Jeffrey Gold via the Gold Charitable Fund – $1,500
- Oskar Demmer – $1,300
- Pearl Baker-Katz – $1,000
- Paul DeJoe – $1,000
- Claudia Marseille – $1,000
- James D. Northrup – $1,000
- Holly Turner – $1,000
- Madhu Kandadai – Ayahuasca Foundation ($5,000)
MAPS relies on the generosity of individual donors to achieve its mission. Psychedelic science is again being conducted under federal guidelines, but no funding for psychedelic psychotherapy research is yet available from governments or major foundations.
MAPS, MAPS Public Benefit Corporation (MAPS PBC), and MAPS Europe are currently hiring!